Drug profile · INN
oseltamivir phosphate
OSELTAMIVIR PHOSPHATE
oseltamivir phosphate (OSELTAMIVIR PHOSPHATE) is a neuraminidase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — oseltamivir phosphate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
oseltamivir phosphate (OSELTAMIVIR PHOSPHATE) is a neuraminidase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Neuraminidase inhibitor
Primary target: Neuraminidase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is oseltamivir phosphate?
oseltamivir phosphate (OSELTAMIVIR PHOSPHATE) is a neuraminidase inhibitor. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for oseltamivir phosphate?
OSELTAMIVIR PHOSPHATE is a marketed brand name for oseltamivir phosphate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of oseltamivir phosphate?
oseltamivir phosphate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.